Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-03-13
• Last 15 days FTD volume: NZ$5.81 M
• Last 3 months FTD volume: NZ$33.24 M
• Last 12 months FTD volume: NZ$0.27 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	NZ$55.5 M	NZ$0.14 B	🇺🇸 USA
Pfizer PFE	NZ$45.54 M	NZ$0.11 B	🇺🇸 USA
AbbVie ABBV	NZ$0.14 B	NZ$0.20 B	🇺🇸 USA
Eli Lilly LLY	NZ$27.23 M	NZ$0.38 B	🇺🇸 USA
Amgen AMGN	NZ$0.27 B	NZ$0.38 B	🇺🇸 USA
Biogen BIIB	NZ$3.11 M	NZ$56.08 M	🇺🇸 USA
Illumina ILMN	NZ$12.26 M	NZ$21.9 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	NZ$19.07 M	NZ$0.10 B	🇺🇸 USA
Merck MRK	NZ$0.12 B	NZ$0.18 B	🇺🇸 USA